How to Manage Your Join Luma Plan

Find your next billing date, scheduled shipment date, current prescription instructions and remaining supply. These answer different questions. A billing date tells you when the next charge is scheduled; a shipment date matters for a six-month partial-refund request; dose dates tell the clinician about continuity and possible gaps.

Do not assume a message changes any of those dates until you have confirmation. When contacting support, identify the specific action you want and whether an order has already billed or shipped. Keep a copy of the request and reply. Your plan pricing and current account details are more useful than guessing from the date the first package arrived.

Cancel upcoming orders anytime before the next billing date through the patient portal or by emailing support@joinluma.com. State clearly that you want future orders canceled and check the confirmation. If you are unsure which date controls your next order, ask support rather than assuming the refill delivery date is the deadline.

Canceling future orders does not refund an order already billed or fulfilled. An administrative cancellation also does not provide a clinical stopping or restarting plan. If you are stopping medication, ask your clinician what to expect and how to approach future treatment, particularly if you have diabetes or another condition requiring ongoing management. Read the terms of service and ask support about the status of a specific order.

Six-month plans ship medication in supplies of up to three months. A six-month plan can be canceled with a partial refund before the next scheduled shipment when you request it at least two business days before that shipping date. Requests made later are not guaranteed, so check the actual scheduled shipment rather than estimating from the plan purchase date.

The period you have received is charged at the three-month rate, and the remaining amount is refunded. This is a recalculation, not simply a promise to return half of the original payment. Ask support to explain the calculation for your plan and confirm whether the request meets the timing requirement. Do not assume that canceling after billing creates a separate refund right for medication already billed or fulfilled.

Contact support before the next billing date to request a different commitment length, such as moving to a six-month plan. Ask when the new plan would begin, which current-user rate applies and what amount would be billed. Do not interpret a monthly equivalent as a promise that a prepaid plan is billed each month.

Current GLP User monthly pricing is $149 for compounded semaglutide or $219 for compounded tirzepatide. Six-month prepaid injection plans are $99/month for semaglutide, $594 total, or $149/month for tirzepatide, $894 total. Affirm, Klarna or Afterpay can split the payment, subject to approval. Compare commitment lengths and oral ODT options on Join Luma’s pricing page.

New-patient pricing helps people new to GLP-1 treatment get started during the first plan period; plans then renew at affordable Current GLP User pricing for the same commitment length. Three-month Current GLP User pricing is $119/month for semaglutide or $179/month for tirzepatide. Plans include clinician oversight, medication if prescribed, necessary supplies and shipping, with no membership fees.

Contact Join Luma support to discuss a pause or a different refill date. There is no published policy promising that either request can be accommodated, so do not assume a pause is automatic, unlimited or available after an order is processed. Ask for written confirmation of what happens to upcoming charges and shipments.

A pause in billing and a medically appropriate treatment gap are different matters. Tell the clinician when you last took medication and ask for instructions before restarting. The Wegovy injection label gives specific guidance after multiple missed doses; the Zepbound label gives missed-dose instructions but not a universal multiweek restart schedule. Neither should be converted into self-directed restart instructions for a compounded prescription.

Discuss a medication or formulation change with your clinician. Your preferences matter, but semaglutide and tirzepatide are not interchangeable milligram for milligram, and weekly injections are not dose-equivalent to once-daily oral ODT tablets. The clinician decides whether to prescribe a change and provides transition directions.

Formulation can also affect pharmacy routing: Hallandale prepares the additive-free formulation, while VialsRx prepares the formulation with glycine or vitamin B12. State availability affects which route is possible. Ask support about billing implications after the clinical plan is clear, rather than using an administrative plan switch as permission to change medication. Explore oral ODT options if you want to discuss a different format.

Complete the Join Luma intake at intake.joinluma.com and disclose your current medication, formulation, prescribed dose, concentration if compounded, and last dose date. Include side effects, recent interruptions and the rest of your medication list. A transfer requires clinical review; it is not an automatic copy of an outside prescription.

See continuing your current GLP-1 dose for what information helps the review. Do not overlap old and new prescriptions or reuse old syringe units without confirmation. The FDA dosing-error alert explains why a concentration change can alter the correct measurement even when the milligram amount is unchanged. Clarify both clinical continuity and the timing of any outside provider cancellation.

Support is available 24/7 at support@joinluma.com or through the patient portal; most inquiries receive a reply within 1–2 hours. That is a typical support response window, not a guarantee of clinician review or an emergency service. Ask support to help route medical questions to your clinician rather than treating a billing reply as dosing authorization.

Include the request, relevant dates and order details for an administrative question. For a medical question, include medication, dose, last dose date and symptoms, and ask that it reach your clinician. Do not share account information publicly or assume a routine support reply constitutes a new prescription.

Seek urgent care for severe abdominal pain, signs of pancreatitis, significant dehydration, or a serious allergic reaction; call 911 for a life-threatening emergency. Do not wait for a portal reply in an emergency. For nonurgent nausea, constipation, appetite changes or uncertainty about the next dose, contact your clinician for a plan tailored to your symptoms.

As the FDA explains, compounded medications are not FDA-approved. Plan management should support the prescribed care rather than replace individualized medical review, whether you are switching, stopping, renewing or transferring in.